Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,859
Closed -$51.6K 660
2024
Q1
$51.6K Sell
1,859
-72,144
-97% -$2M ﹤0.01% 458
2023
Q4
$2.13M Buy
+74,003
New +$2.24M 0.13% 202
2022
Q4
Sell
-47,829
Closed -$2.09M 1264
2022
Q3
$2.09M Buy
47,829
+33,530
+234% +$1.63M 0.07% 342
2022
Q2
$750K Buy
+14,299
New +$729K 0.03% 603
2022
Q1
Sell
-45,258
Closed -$2.35M 2221
2021
Q4
$2.67M Buy
45,258
+18,134
+67% +$898K 0.09% 253
2021
Q3
$1.17M Buy
+27,124
New +$1.2M 0.04% 684
2020
Q4
Sell
-127,952
Closed -$4.69M 1975
2020
Q3
$4.46M Buy
127,952
+22,688
+22% +$795K 0.47% 47
2020
Q2
$3.27M Sell
105,264
-48,010
-31% -$1.63M 0.36% 56
2020
Q1
$4.75M Buy
153,274
+121,042
+376% +$4.12M 2.09% 10
2019
Q4
$1.2M Sell
32,232
-4,322
-12% -$154K 0.28% 39
2019
Q3
$1.25M Buy
36,554
+10,717
+41% +$390K 0.36% 29
2019
Q2
$1.06M Buy
25,837
+18,088
+233% +$718K 0.29% 34
2019
Q1
$312K Buy
+7,749
New +$310K 0.12% 93
2018
Q4
Sell
-7,542
Closed -$315K 1135
2018
Q3
$315K Buy
7,542
+2,467
+49% +$95K 0.11% 111
2018
Q2
$175K Buy
5,075
+5,005
+7,150% +$171K 0.06% 192
2018
Q1
$2K Buy
+70
New +$2.41K ﹤0.01% 799
2017
Q2
Sell
-5,991
Closed -$194K 982
2017
Q1
$194K Buy
+5,991
New +$189K 0.25% 58
2016
Q3
Sell
-4,743
Closed -$158K 836
2016
Q2
$158K Buy
+4,743
New +$151K 0.18% 127
2015
Q2
Sell
-28,595
Closed -$944K 239
2015
Q1
$944K Buy
+28,595
New +$909K 0.83% 12

Other funds holding PFE

Point72 Hong Kong's PFE Position: Q2 2024 in Review

Point72 Hong Kong sold out of Pfizer (PFE) in Q2 2024, closing a stake of 1,859 shares — an estimated $51.6K sold.

Point72 Hong Kong first reported a position in PFE in Q1 2015 and held it in 19 quarters. The position peaked at $4.75M in Q1 2020. 2,879 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Point72 Hong Kong reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 1,859 Pfizer shares in Q2 2024, an estimated $51.6K.
  • Point72 Hong Kong first reported a position in Pfizer in Q1 2015 and held it in 19 quarters.
  • Point72 Hong Kong's Pfizer position peaked at $4.75M in Q1 2020.
  • 2,879 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.